ArticleAnnals of medicine2022

Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing.

Alpo Vuorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.